Skip to main content

High Tide Inc. (HITI) Stock Forecast

Data as of Sep 20, 2026

Healthcare · Current price $2.58 (-2.45%)

Consensus Target
$2.70
Upside
+4.5%
Analysts
1
Rating
Buy(2.00)

Price Target Range

Low $2.70High $2.70

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

No ratings in the last 3 months.
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0

6-Month Trend

No rating trend data.

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

HITI vs Sector & Market

MetricHITIHealthcare AvgLarge Cap Avg
Analyst Rating2.002.262.42
Analyst Count1818
Target Upside+4.5%+22243.7%+21.5%
P/E Ratio-6.483.7738.34

Revenue Estimates

PeriodLowAvgHigh#
2026-10-31$185M$189M$194M3
2027-01-31$191M$195M$200M3
2027-04-30$188M$192M$197M2
2027-07-31$199M$204M$209M3
2027-10-31$207M$212M$217M3
2028-10-31$865M$886M$907M2
2029-10-31$908M$931M$953M1
2030-10-31$966M$990M$1.01B1

EPS Estimates

PeriodLowAvgHigh#
2026-10-31$0.03$0.03$0.041
2027-01-31$0.04$0.04$0.041
2027-04-30$0.03$0.04$0.041
2027-07-31$0.07$0.07$0.071
2027-10-31$0.07$0.08$0.081
2028-10-31$0.30$0.31$0.312
2029-10-31$0.46$0.48$0.491
2030-10-31$0.55$0.57$0.591

Frequently Asked Questions

What is the analyst consensus for HITI?

The consensus among 1 analysts covering High Tide Inc. (HITI) is Buy with an average price target of $2.70.

What is the highest price target for HITI?

The highest analyst price target for HITI is $2.70.

What is the lowest price target for HITI?

The lowest analyst price target for HITI is $2.70.

How many analysts cover HITI?

1 analysts have issued ratings for High Tide Inc. in the past 12 months.

Is HITI a buy or sell right now?

Based on 1 analyst ratings, HITI has a consensus rating of Buy (2.00/5) with a +4.5% upside to the consensus target of $2.70.

What are the earnings estimates for HITI?

Analysts estimate HITI will report EPS of $0.03 for the period ending 2026-10-31, with revenue estimated at $189M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.